全文获取类型
收费全文 | 3065篇 |
免费 | 234篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 56篇 |
妇产科学 | 27篇 |
基础医学 | 377篇 |
口腔科学 | 72篇 |
临床医学 | 426篇 |
内科学 | 600篇 |
皮肤病学 | 35篇 |
神经病学 | 271篇 |
特种医学 | 104篇 |
外科学 | 395篇 |
综合类 | 42篇 |
一般理论 | 2篇 |
预防医学 | 311篇 |
眼科学 | 59篇 |
药学 | 227篇 |
中国医学 | 2篇 |
肿瘤学 | 279篇 |
出版年
2022年 | 28篇 |
2021年 | 53篇 |
2020年 | 36篇 |
2019年 | 49篇 |
2018年 | 67篇 |
2017年 | 50篇 |
2016年 | 51篇 |
2015年 | 57篇 |
2014年 | 96篇 |
2013年 | 150篇 |
2012年 | 190篇 |
2011年 | 226篇 |
2010年 | 112篇 |
2009年 | 104篇 |
2008年 | 195篇 |
2007年 | 207篇 |
2006年 | 186篇 |
2005年 | 201篇 |
2004年 | 164篇 |
2003年 | 187篇 |
2002年 | 190篇 |
2001年 | 51篇 |
2000年 | 29篇 |
1999年 | 44篇 |
1998年 | 42篇 |
1997年 | 27篇 |
1996年 | 29篇 |
1995年 | 20篇 |
1994年 | 21篇 |
1993年 | 20篇 |
1992年 | 21篇 |
1991年 | 45篇 |
1990年 | 21篇 |
1989年 | 14篇 |
1988年 | 21篇 |
1987年 | 16篇 |
1986年 | 14篇 |
1985年 | 18篇 |
1984年 | 13篇 |
1983年 | 15篇 |
1981年 | 13篇 |
1979年 | 14篇 |
1978年 | 23篇 |
1977年 | 16篇 |
1976年 | 11篇 |
1975年 | 11篇 |
1974年 | 18篇 |
1972年 | 15篇 |
1971年 | 16篇 |
1969年 | 11篇 |
排序方式: 共有3309条查询结果,搜索用时 15 毫秒
21.
22.
23.
Lance A. Belchetz M.D. Theresa Berk M.S.S.A. Bharati V. Bapat Ph.D. Zane Cohen M.D. Steven Gallinger M.D. 《Diseases of the colon and rectum》1996,39(4):384-387
Widespread use of prophylactic colectomy has resulted in a reduction in the incidence of colorectal cancer in familial adenomatous polyposis (FAP) patients. A retrospective chart review of families registered at the Steve Atanas Stavro Familial Gastrointestinal Cancer Registry in Toronto was performed to determine whether the decrease in the number of patients developing colorectal cancer implies that causes of mortality in FAP patients are shifting to that of extracolonic manifestations of FAP. Information was available on 140 deaths within 158 families and among 461 individuals with FAP. When stratified by decade, from the 1930s to the 1990s, the ratio of deaths caused by extracolonic manifestations of FAP compared with deaths caused by colorectal cancer was noted to have risen. Even though most deaths in FAP patients are still from colorectal cancer, it appears that screening policies and prophylactic colectomy have resulted in a reduction in the number of FAP patients who develop colorectal cancer. Thus, in recent decades, a greater percentage of deaths in FAP patients appears to be attributable to extracolonic manifestations of the disease. 相似文献
24.
Robert B. Livingston Lance H. Heilbrun Southwest Oncology Group 《Cancer chemotherapy and pharmacology》1978,1(4):225-227
Summary In a large study of combination chemotherapy for patients with extensive squamous carcinoma of the lung, 44 of 247 patients (18%) achieved>50% regression of tumor mass. The likelihood of response was significantly (and independently) higher for females and for fully ambulatory patients. Bone and liver were the most commonly involved metastatic sites, with documented involvement pretreatment in 32 and 16% of patients, respectively. Recurrence in the ipsilateral hemithorax after radiation therapy was the only clinical evidence of disease in 24% of the patients. There were no significant differences in response rate by individual metastatic sites, or for single compared to multiple sites. The median time to response was 4 weeks, with response noted by 8 weeks in 74%.Clinically evident relapse has occurred in 39. Among these, the primary site was the only clinical site of failure in 14, of whom 7 never received radiation therapy. The brain was the only site of initial failure in 6, only 1 of whom had preexisting evidence of brain involvement. Failure in a single area of previously evident disease or the brain accounted for 74% of recurrences in the responding group. These observations suggest that sequential, planned radiation therapy to sites of previous clinical involvement, together with prophylactic whole-brain radiation, may be of benefit in the drug-responsive subpopulation of patients with extensive disease. 相似文献
25.
The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. 总被引:6,自引:0,他引:6
26.
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. 总被引:1,自引:0,他引:1
Emanuel F Petricoin Verena E Bichsel Valerie S Calvert Virginia Espina Mary Winters Lynn Young Claudio Belluco Bruce J Trock Marc Lippman David A Fishman Dennis C Sgroi Peter J Munson Laura J Esserman Lance A Liotta 《Journal of clinical oncology》2005,23(15):3614-3621
Mapping tumor cell protein networks in vivo will be critical for realizing the promise of patient-tailored molecular therapy. Cancer can be defined as a dysregulation or hyperactivity in the network of intracellular and extracellular signaling cascades. These protein signaling circuits are the ultimate targets of molecular therapy. Each patient's tumor may be driven by a distinct series of molecular pathogenic defects. Thus, for any single molecular targeted therapy, only a subset of cancer patients may respond. Individualization of therapy, which tailors a therapeutic regimen to a tumor molecular portrait, may be the solution to this dilemma. Until recently, the field lacked the technology for molecular profiling at the genomic and proteomic level. Emerging proteomic technology, used concomitantly with genomic analysis, promises to meet this need and bring to reality the clinical adoption of molecular stratification. The activation state of kinase-driven signal networks contains important information relative to cancer pathogenesis and therapeutic target selection. Proteomic technology offers a means to quantify the state of kinase pathways, and provides post-translational phosphorylation data not obtainable by gene arrays. Case studies using clinical research specimens are provided to show the feasibility of generating the critical information needed to individualize therapy. Such technology can reveal potential new pathway interconnections, including differences between primary and metastatic lesions. We provide a vision for individualized combinatorial therapy based on proteomic mapping of phosphorylation end points in clinical tissue material. 相似文献
27.
Christopher G Willett Yves Boucher Dan G Duda Emmanuelle di Tomaso Lance L Munn Ricky T Tong Sergey V Kozin Lucine Petit Rakesh K Jain Daniel C Chung Dushyant V Sahani Sanjeeva P Kalva Kenneth S Cohen David T Scadden Alan J Fischman Jeffrey W Clark David P Ryan Andrew X Zhu Lawrence S Blaszkowsky Paul C Shellito Mari Mino-Kenudson Gregory Y Lauwers 《Journal of clinical oncology》2005,23(31):8136-8139
28.
Azure D. Grant Dana M. Lewis Lance J. Kriegsfeld 《Journal of diabetes science and technology》2022,16(4):912
Background:Blood glucose and insulin exhibit coordinated daily and hourly rhythms in people without diabetes (nonT1D). Although the presence and stability of these rhythms are associated with euglycemia, it is unknown if they (1) are preserved in individuals with type 1 diabetes (T1D) and (2) vary by therapy type. In particular, Hybrid Closed Loop (HCL) systems improve glycemia in T1D compared to Sensor Augmented Pump (SAP) therapies, but the extent to which either recapitulates coupled glucose and insulin rhythmicity is not well described. In HCL systems, more rapid modulation of glucose via automated insulin delivery may result in greater rhythmic coordination and euglycemia. Such precision may not be possible in SAP systems. We hypothesized that HCL users would exhibit fewer hyperglycemic event, superior rhythmicity, and coordination relative to SAP users.Methods:Wavelet and coherence analyses were used to compare glucose and insulin delivery rate (IDR) within-day and daily rhythms, and their coordination, in 3 datasets: HCL (n = 150), SAP (n = 89), and nonT1D glucose (n = 16).Results:Glycemia, correlation between normalized glucose and IDR, daily coherence of glucose and IDR, and amplitude of glucose oscillations differed significantly between SAP and HCL users. Daily glucose rhythms differed significantly between SAP, but not HCL, users and nonT1D individuals.Conclusions:SAP use is associated with greater hyperglycemia, higher amplitude glucose fluctuations, and a less stably coordinated rhythmic phenotype compared to HCL use. Improvements in glucose and IDR rhythmicity may contribute to the overall effectiveness of HCL systems. 相似文献
29.
Distribution of single wall carbon nanotubes in the Xenopus laevis embryo after microinjection 下载免费PDF全文
Kris Noel Dahl Lance A. Davidson Mohammad F. Islam 《Journal of applied toxicology : JAT》2016,36(4):568-578
Single wall carbon nanotubes (SWCNTs) are advanced materials with the potential for a myriad of diverse applications, including biological technologies and large‐scale usage with the potential for environmental impacts. SWCNTs have been exposed to developing organisms to determine their effects on embryogenesis, and results have been inconsistent arising, in part, from differing material quality, dispersion status, material size, impurity from catalysts and stability. For this study, we utilized highly purified SWCNT samples with short, uniform lengths (145 ± 17 nm) well dispersed in solution. To test high exposure doses, we microinjected > 500 µg ml–1 SWCNT concentrations into the well‐established embryogenesis model, Xenopus laevis, and determined embryo compatibility and subcellular localization during development. SWCNTs localized within cellular progeny of the microinjected cells, but were heterogeneously distributed throughout the target‐injected tissue. Co‐registering unique Raman spectral intensity of SWCNTs with images of fluorescently labeled subcellular compartments demonstrated that even at regions of highest SWCNT concentration, there were no gross alterations to subcellular microstructures, including filamentous actin, endoplasmic reticulum and vesicles. Furthermore, SWCNTs did not aggregate and localized to the perinuclear subcellular region. Combined, these results suggest that purified and dispersed SWCNTs are not toxic to X. laevis animal cap ectoderm and may be suitable candidate materials for biological applications. Copyright © 2015 John Wiley & Sons, Ltd. 相似文献